Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Case of Mistaken Identity Leads to Much-Needed Drug Target Against MRSA, Gram-Positive Infections

03.02.2015

The increasing prevalence of antibiotic resistance, when infectious bacteria evolve to evade drugs designed to control them, is a pressing public health concern. Each year two million Americans acquire antibiotic-resistant infections, leading to 23,000 deaths. In light of these unsettling statistics, there has been a call to develop new weapons to combat bacterial threats to human health.

Scientists at the University of Utah and the University of Georgia have uncovered a pharmacological target that could enable development of novel drugs against antibiotic-resistant pathogens, including Methicillin-resistant Staphylococcus aureus (MRSA) and other infectious Gram-positive organisms such as Listeria and Mycobacterium tuberculosis.


by NIAID_Flickr. Licensed under CC BY 2.0 via Wikimedia Commons –

Scanning electron micrograph of Methicillin-resistant Staphylococcus aureus (MRSA) and a dead Human neutrophil

The target was revealed upon discovery of a Gram-positive bacteria-specific pathway for making heme, an essential iron-carrying molecule. The findings were reported in the journal, Proceedings of the National Academy of Sciences (PNAS).

“The therapeutic target could be used to create a completely new class of drugs for fighting Gram-positive bacteria including those that cause antibiotic-resistant infections,” says John Phillips, Ph.D., senior author of the paper and research professor in hematology at the University of Utah School of Medicine.

The fortuitous discovery was an outcome of a quest to solve a case of mistaken identity. For the past 100 years, the prevailing notion was that every organism – from bacteria to man – used the same eight-step recipe to make the essential, snowflake-shaped iron transporter, heme.

That’s why Harry Dailey, Ph.D., first author and biochemistry professor at the University of Georgia, was puzzled when he noticed that proteins that were given the name HemN, a key component of the historically-defined heme pathway, looked very different in Gram-positive bacteria than in other classes of bacteria. The code of amino acids – building blocks of proteins – that were recorded as Gram-positive “HemN” didn’t match up with the rest.

“It made me wonder, ‘What do we know, as opposed to what do we think we know?’” recalled Harry Dailey, Ph.D., first author and professor of biochemistry at the University of Georgia.

In the lab, he found that the so-called Gram-positive bacteria “Heme N” was, in fact, incapable of making heme. Determined to figure out what substitutes for HemN, Dailey collaborated with Phillips to purify components of the heme pathway in Gram-positive bacteria.

Like figuring out how to make a cake by seeing how it looks after each step of the recipe is completed, they collected the intermediates of the heme pathway, and determined that the last three were completely different than expected. Biochemical experiments further showed that a Gram-positive specific enzyme called HemQ is required for the final step. A survey of heme pathway components in over 350 other organisms support the idea that only Gram-positive bacteria use the alternate, HemQ-dependent recipe for making heme.

The implications were immediately obvious to Dailey and Phillips. “A drug that disables HemQ, will knock out heme biosynthesis only in Gram-positive bacteria, sparing this important pathway in our own cells,” explains Dailey. He has already demonstrated that genetically eliminating HemQ severely disables the troublesome germs, suggesting a drug that targets the protein will do the same. If screens against existing compounds identify one that is capable of blocking HemQ, a drug could be available in as quickly as two years; development of a new antibiotic could take ten years.

“The original goal of this work was to sort out the naming of different bacterial genes, but the result was identifying a completely new metabolic pathway that can be exploited to improve healthcare,” says Phillips. “It’s a reminder that, to paraphrase Louis Pasteur, chance favors the prepared mind.”

The study was supported by the National Institutes of Health.

Co-authors include Tamara Dailey and Joseph Burch of the University of Georgia, and Svetlana Gerdes of the Argonne National Laboratory.

Noncanonical coproporphyrin-dependent bacterial heme biosynthesis pathway that does not use protoporphyrin. PNAS Early Edition, Feb. 2, 2015

Contact Information
Julie Kiefer
Communications Specialist
jkiefer@neuro.utah.edu
Phone: 801-597-4258

Julie Kiefer | newswise
Further information:
http://unews.utah.edu/

More articles from Life Sciences:

nachricht The birth of a new protein
20.10.2017 | University of Arizona

nachricht Building New Moss Factories
20.10.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>